Lipids and liver dysfunction in patients receiving parenteral nutrition

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 16, Issue 2, 2013, Pages 150-155

  Gabe, Simon M ^a,b  

^a ST MARK S HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

fish oil; intestinal failure; lipid emulsion; liver disease; parenteral nutrition; phytosterol; vitamin E

Indexed keywords

ALPHA TOCOPHEROL; CLINOLEIC; LIPID EMULSION; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PHYTOSTEROL; POLYUNSATURATED FATTY ACID;

ANTIOXIDANT ACTIVITY; HEPATOBILIARY DISEASE; HUMAN; LIVER DYSFUNCTION; LIVER FUNCTION TEST; PARENTERAL NUTRITION; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW;

ANTIOXIDANTS; EMULSIONS; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; FISH OILS; HUMANS; LIPIDS; LIVER DISEASES; LIVER FUNCTION TESTS; PARENTERAL NUTRITION; PHYTOSTEROLS; PLANT OILS; RISK FACTORS; SOYBEAN OIL; TRIGLYCERIDES;

EID: 84873406815     PISSN: 13631950     EISSN: 14736519     Source Type: Journal    
DOI: 10.1097/MCO.0b013e32835dbcf4     Document Type: Review

References (36)

1. Wiles A, Woodward JM. Recent advances in the management of intestinal failure-associated liver disease. Curr Opin Clin Nutr Metab Care 2009; 12:265-272.
2. Lloyd DA, Gabe SM. Managing liver dysfunction in parenteral nutrition. Proc Nutr Soc 2007; 66:530-538.
3. Baker ML, Nightingale JMD. Abnormal liver function tests and parenteral nutrition. Clin Nutr 2004; 23:864-865. [abstract].
4. Salvino R, Ghanta R, Seidner DL, et al. Liver failure is uncommon in adults receiving long-term parenteral nutrition. JPEN J Parenter Enteral Nutr 2006; 30:202-208.
5. Cavicchi M, Beau P, Crenn P, et al. Prevalence of liver disease and contributing factors in patients receiving home parenteral nutrition for permanent intestinal failure. Ann Intern Med 2000; 132:525-532.
6. Quigley EM, Marsh MN, Shaffer JL, Markin RS. Hepatobiliary complications of total parenteral nutrition. Gastroenterology 1993; 104:286-301.
7. Cober MP, Teitelbaum DH. Prevention of parenteral nutrition-associated liver disease: lipid minimization. Curr Opin Organ Transplant 2010; 15:330-333.
8. Sondheimer JM, Asturias E, Cadnapaphornchai M. Infection and cholestasis in neonates with intestinal resection and long-term parenteral nutrition. J Pediatr Gastroenterol Nutr 1998; 27:131-137.
9. Meguid MM, Akahoshi MP, Jeffers S, et al. Amelioration of metabolic complications of conventional total parenteral nutrition. A prospective randomized study. Arch Surg 1984; 119:1294-1298.
10. Bigorgne C, Le Tourneau A, Vahedi K, et al. Sea-blue histiocyte syndrome in bone marrow secondary to total parenteral nutrition. Leuk Lymphoma 1998; 28:523-529.
11. Colomb V, Jobert-Giraud A, Lacaille F, et al. Role of lipid emulsions in cholestasis associated with long-term parenteral nutrition in children. JPEN J Parenter Enteral Nutr 2000; 24:345-350.
12. Shin JI, Namgung R, Park MS, Lee C. Could lipid infusion be a risk for parenteral nutrition-associated cholestasis in low birth weight neonates? Eur J Pediatr 2008; 167:197-202.
13. Luman W, Shaffer J. Prevalence, outcome and associated factors of deranged liver function tests in patients on home parenteral nutrition. Clin Nutr 2002; 21:337-343.
14. Clayton PT, Whitfield P, Iyer K. The role of phytosterols in the pathogenesis of liver complications of pediatric parenteral nutrition. Nutrition 1998; 14:158-164.
15. Fallon EM, Le HD, Puder M. Prevention of parenteral nutrition-associated liver disease: role of omega-3 fish oil. Curr OpinOrgan Transplant 2010; 15:334-340.
16. Waitzberg DL, Torrinhas RS, Jacintho TM. New parenteral lipid emulsions for clinical use. JPEN J Parenter Enteral Nutr 2006; 30:351-367.
17. Sala-Vila A, Barbosa VM, Calder PC.Olive oil in parenteral nutrition. CurrOpin Clin Nutr Metab Care 2007; 10:165-174.
18. Thomas-Gibson S, Jawhari A, Atlan P, et al. Safe and efficacious prolonged use of an olive oil-based lipid emulsion (ClinOleic) in chronic intestinal failure. Clin Nutr 2004; 23:697-703.
19. Yeh SL, Chang KY, Huang PC, Chen WJ. Effects of n-3 and n-6 fatty acids on plasma eicosanoids and liver antioxidant enzymes in rats receiving total parenteral nutrition. Nutrition 1997; 13:32-36.
20. Heller AR, Rossel T, Gottschlich B, et al. Omega-3 fatty acids improve liver and pancreas function in postoperative cancer patients. Int J Cancer 2004; 111:611-616.
21. Clayton PT, Bowron A, Mills KA, et al. Phytosterolemia in children with parenteral nutrition-associated cholestatic liver disease. Gastroenterology 1993; 105:1806-1813.
22. Kast HR, Goodwin B, Tarr PT, et al. Regulation of multidrug resistanceassociated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor. J Biol Chem 2002; 277:2908-2915.
23. Carter BA, Taylor OA, Prendergast DR, et al. Stigmasterol, a soy lipid-derived phytosterol, is an antagonist of the bile acid nuclear receptor FXR. Pediatr Res 2007; 62:301-306.
24. Steger PJ, Muhlebach SF. Lipid peroxidation of i.v. lipid emulsions in TPN bags: the influence of tocopherols. Nutrition 1998; 14:179-185.
25. Sanyal AJ, Chalasani N, Kowdley KV, et al. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N Engl J Med 2010; 362:1675-1685.
26. Buchman AL, Scolapio J, Fryer J. AGA technical review on short bowel syndrome and intestinal transplantation. Gastroenterology 2003; 124:1111-1134.
27. Koletzko B, Goulet O, Hunt J, et al. 1. Guidelines on Paediatric Parenteral Nutrition of the European Society of Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) and the European Society for Clinical Nutrition and Metabolism (ESPEN), Supported by the European Society of Paediatric Research (ESPR). J Pediatr Gastroenterol Nutr 2005; 41 (Suppl 2):S1-S87.
28. Palova S, Charvat J, Kvapil M. Comparison of soybean oil-and olive oil-based lipid emulsions on hepatobiliary function and serum triacylglycerols level during realimentation. J Int Med Res 2008; 36:587-593.
29. Demirel G, Oguz SS, Celik IH, et al. The metabolic effects of two different lipid emulsions used in parenterally fed premature infants-a randomized comparative study. Early Hum Dev 2012; 88:499-501.
30. Gura KM, Lee S, Valim C, et al. Safety and efficacy of a fish-oil-based fat emulsion in the treatment of parenteral nutrition-associated liver disease. Pediatrics 2008; 121:e678-e686.
31. Puder M, Valim C, Meisel JA, et al. Parenteral fish oil improves outcomes in patients with parenteral nutrition-associated liver injury. Ann Surg 2009; 250:395-402.
32. Gura KM, Duggan CP, Collier SB, et al. Reversal of parenteral nutritionassociated liver disease in two infants with short bowel syndrome using parenteral fish oil: implications for future management. Pediatrics 2006; 118:e197-e201.
33. Burns DL, Gill BM. Reversal of parenteral nutrition-associated liver disease with a fish oil-based lipid emulsion (Omegaven) in an adult dependent on home parenteral nutrition. JPEN J Parenter Enteral Nutr 2012 [Epub ahead of print]. doi: 10.1177/0148607112450301
34. Muhammed R, Bremner R, Davies P, et al. A sudden and marked reduction in PN cholestasis on changing from a conventional intravenous lipid source to SMOFlipid [abstract]. J Pediatr Gastroenterol Nutr 2009; 48 (Suppl 3): E140.
35. Goulet O, Antebi H, Wolf C, et al. A new intravenous fat emulsion containing soybean oil, medium-chain triglycerides, olive oil, and fish oil: a single-center, double-blind randomized study on efficacy and safety in pediatric patients receiving home parenteral nutrition. JPEN J Parenter Enteral Nutr 2010; 34:485-495.
36. Klek S, Chambrier C, Singer P, et al. Four-week parenteral nutrition using a third generation lipid emulsion (SMOFlipid)-a double-blind, randomised, multicentre study in adults. Clin Nutr 2012 [Epub ahead of print]. doi: 10.1016/j.clnu.2012.06.011